Skip to content

Clinical trials

Phase 3 Hyperphagia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperphagia Phase: Phase 3 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20081
20091
20121
20141
20151
20161
20181
20212
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire6
Aardvark Therapeutics, Inc.2
Rhythm Pharmaceuticals, Inc.2
Fresenius Kabi1
NICHD Neonatal Research Network1
Pediatrix1
University of South Florida1
Zafgen, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperphagia15
Short Bowel Syndrome6
Prader-Willi Syndrome3
Obesity2
Premature Birth2
Bardet-Biedl Syndrome1
Cholestasis1
Liver Diseases1
Malnutrition1
Sepsis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.